OxThera’s Oxabact Receives EMA’s Positive Decision on Pediatric Investigational Plan to Treat Primary Hyperoxaluria Published: Aug 23, 2019 | Tags: OxThera, Oxabact, Receives, EMA, Positive Decision, Pediatric Investigational Plan, Treat, Primary […]readmore
Tags : CVRx
Shots: The US FDA’s PMA is based on P-III BeAT-HF study confirming the safety of Barostim Neo and its effectiveness in improving symptoms in 264 patients with chronic heart failure. […]readmore